The Incidence of Prostate Adenocarcinoma in Patients Who Underwent Cystoprostatectomy for Invasive Baldder Cancer and Histopathological Examination
Journal Title: Üroonkoloji Bülteni - Year 2016, Vol 15, Issue 2
Abstract
Objective: It was aimed to evaluate the incidence of prostate adenocarcinoma in patients treated by cystoprostatectomy for invasive bladder urothelial carcinoma and to demonstrate the histopathological features of prostate cancer cases. Materials and Methods: Between January 2010 and April 2015, totally 119 invasive bladder urothelial carcinoma patients operated by cystoprostatectomy without the diagnosis of prostate adenocarcinoma preoperatively were included into the study. The pathological records of patients were analyzed retrospectively. The patients were classified according to TNM system. Results: Prostate adenocarcinoma was detected in cystoprostatectomy materials of 16 patients (13.4%) and only 4 of the patients (25%) had clinically substantial prostate cancer. The average age was 62,3 (43-78, range) years. The pathological results of bladder urothelial carcinoma revealed as T2a in 4 (25%) patients, T2b in 4 (25%) patients, T3a in 6 (37.5%) patients and T4 only in 2 (12.5%) patients. Lymph node metastasis was detected in 5 (31.2%) patients and carcinoma in situ was detected in 5 (31.2%) patients. The mean follow-up time was 27.1 (463) months. The Gleason score of prostate cancer was 3+3 in 12 (75%) patients, 3+4 in 2 (12.5%) patient, 4+4 in 1 (6.25%) patient and 4+5 in 1 (6.25%) patient. The stages of prostate cancer were T2a in 14 (87.5%) patients, T2b in 1 (6.25%) patient and T3a in 1 (6.25%) patient. Conclusion: Life expectancy of the patients who had radical cystoprostatectomy due to invasive bladder tumor was affected dramatically by the pathological stage of urothelial carcinoma. Therefore, prostate-sparing radical cystectomy techniques can be used as alternative surgical methods for younger and chosen patients to minimize continence and erectile problems and to improve the quality of life.
Authors and Affiliations
Yasin Ceylan, Volkan Şen, Salih Polat, Bülent Günlüsoy, Tansu Değirmenci, Yusuf Kadir Topçu, Deniz Bolat, Zafer Kozacıoğlu
Keywords
Related Articles
- EP ID EP228336
- DOI 10.4274/uob.647
- Views 80
- Downloads 0
Information about Prostate Cancer for Urologist: Ga-68 Prostate Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Scintigraphy
Recently, prostate-specific membrane antigen (PSMA), a glutamate carboxypeptidase II enzyme, has transformed intoan excited radiopharmaceutical agent as a result of radiolabeling of small peptides that are developed for...
Current Status of Oligometastatic Prostate Cancer: Risk Factors and Treatment Approaches
Prostate cancer (PCa) is a common disease that causes significant mortality rates. The widespread use of more sophisticated imaging methods has led to the identification of oligometastatic PCa, which has a limited number...
Oncocytic Adrenocortical Carcinoma: A Rare Case Report
Oncocytic neoplasms of the adrenal cortex are uncommon and generally benign and non-functioning. About 20% of adrenocortical oncocytic neoplasms show malignant components. A 39-year-old woman with an adrenocortical oncoc...
Transperitoneal Laparoscopic Nephrectomy-Our Initial Experiences
Objective: To evaluate the first experiences of laparoscopic nephrectomy operations performed in our clinics. Materials and Methods: A total of 61 laparoscopic nephrectomy operations were performed in our clinics during...
The Effect of Tumor Size on Oncologic Outcomes in Pathological T2 Stage Renal Cell Carcinoma Patients
Objective: To evaluate the oncologic outcomes in T2 stage renal cell carcinoma (RCC) patients who underwent open radical nephrectomy and the effect of patient’s tumor size on the oncologic outcomes. Materials and Methods...